Human Y-chromosome variation and male dysfunction by de Carvalho, Cláudia Márcia Benedetto & Santos, Fabrício Rodrigues
 
© Carvalho and Santos | Journal of Molecular and Genetic Medicine | December 2005 | Vol 1, No 2 | 63-75 | OPEN ACCESS 
63 
 
REVIEW 
 
 
 
Human Y-chromosome variation and male dysfunction 
 
Cláudia Márcia Benedetto de Carvalho
1,2 and Fabrício Rodrigues Santos
2* 
 
1Departamento de Bioquímica e Imunologia, and 
2Departamento de Biologia Geral, Instituto de Ciências Biológicas, 
Universidade Federal de Minas Gerais, Belo Horizonte, Minas Gerais, Brazil 
 
*Correspondence to: Fabrício Rodrigues Santos, Email: fsantos@icb.ufmg.br, Tel: +55 31 3499 2581, Fax: +55 31 3499 2570 
 
Journal of Molecular and Genetic Medicine (2005), 1(2), 63-75 
© Copyright Carvalho and Santos 
 
(Received 26 August 2005; Revised 30 September 2005; Accepted 05 October 2005; Available online 06 December 2005; Published 
30 December 2005) 
 
 
ABSTRACT 
 
The Y-chromosome is responsible for sex determination in mammals, which is triggered by the expression of 
the SRY gene, a testis-determining factor. This particular gene, as well as other genes related to male fertility, 
are located in the non-recombining portion of the Y (NRY), a specific region that encompasses 95% of the 
human Y-chromosome. The other 5% is composed of the pseudo-autosomal regions (PARs) at the tips of Yp 
and Yq, a X-chromosome homologous region used during male meiosis for the correct pairing of sexual 
chromosomes. Despite of the large size of the human NRY (about 60 Mb), only a few active genes are found 
in this region, most of which are related to fertility. Recently, several male fertility dysfunctions were associ-
ated to microdeletions by STS mapping. Now that the complete genetic map of the human Y-chromosome is 
available, the role of particular NRY genes in fertility dysfunctions is being investigated. Besides, along with 
the description of several nucleotide and structural variations in the Y-chromosome, the association between 
phenotype and genotype is being addressed more precisely. Particularly, several research groups are investi-
gating the association between Y-chromosome types and susceptibility to certain male dysfunctions in dif-
ferent population backgrounds. New insights on the role of the Y-chromosome and maleness are being en-
visaged by this approach. 
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INTRODUCTION 
 
The mammalian Y-chromosome is a degenerated X chro-
mosome (both derived from an ancestral autosome pair), 
which has lost several housekeeping genes becoming spe-
cialized in male sex determination. A number of studies 
have suggested, erroneously, that some traits such as vio-
lent character, hairy ear, etc., could be mapped on the Y-
chromosome. More recently, it has been demonstrated that 
some of the Y-chromosome genes are implicated in dys-
functions,  such  as  infertility,  gonadal  sex reversion,  go-
nadoblastoma  and  non-syndromic  hearing  impairment. 
Furthermore, a number of studies also claim that other Y-
chromosome genes are associated with high blood pres-
sure  and  prostate  cancer.  However,  this  requires  further 
investigation. This review intends to provide an overview 
of new evidences of the Y function and of the probable 
genes involved in male phenotypes. 
 
THE HUMAN Y-CHROMOSOME 
 
The sex chromosomes, X and Y, emerged from an auto-
some pair around 300 million years ago among the first 
mammals (Lahn et al, 2001). Since then, they have been 
diverging because of their different functional roles. The 
Y-chromosome has become specialized in the male sex 
determination, progressively decreasing its gene content 
by losing and gaining sequences through the action of 
events, such as, deletions, mutations, insertions, recom-
bination  and  transposition,  etc.,  (reviewed  in  
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Charlesworth et al, 2005). The divergence between X- 
and Y-chromosomes has broken down their homology, 
generating obstacles for recombination between the two 
sex  chromosomes.  This  evolutionary  process  has  also 
produced Y-chromosomes with remarkable differences, 
including between closely-related species as human and 
chimpanzee  (Hughes  et  al,  2005).  In  the  human  Y-
chromosome, meiotic recombination takes place in two 
relatively short regions (approximately 3 Mb of its ~60 
Mb length), namely Yp- and Yq-PAR (pseudo-autosomal 
region)  that  pair  with  the  X-chromosome.  They  are 
placed at the tips of the X- and Y-chromosomes (Figure 
1) and the high homology between them is kept by the 
obligatory  crossing-over  during  male  meiosis,  which 
assures the correct pairing and segregation of X and Y. 
Despite  of  the  occurrence  of  many  X-homologous  re-
gions  distributed  along  the  Y-chromosome,  most  of 
these  do  not  recombine  and  are  designated  as  NRY 
(Non-Recombining Y). Skaletsky et al (2003) renamed 
NRY region to MSY (Figure 1) or “male-specific region 
of  the  Y”  because  they  observed  that  the  designation 
"non-recombining  region"  did  not  reflect  the  dynamic 
evolutionary  events  happening  in  this  part  of  the  Y-
chromosome. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic display of the human Y-chromosome showing pseudo-autosomal regions (PARs), the male specific region 
(MSY or NRY), the heterochromatic regions, the main genes on the euchromatic region and the regions associated with male dys-
functions (adapted from Skaletsky et al, 2003, and Jobling and Tyler-Smith, 2003). 
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The Y-chromosome forms 2-3% of the haploid genome, 
most of which is heterochromatic, around ~40 Mb in size 
(Figure 1). The heterochromatic region is made up of three 
blocks (Figure 1); the first (1 Mb) is placed at the centro-
mere (cen), the second one (DYZ19) in the middle of Yq 
(~400 Kb) and the third one comprise most of distal Yq. 
All  three  blocks  consist  of  massively  amplified  tandem 
repeats of low sequence complexity.  
 
The  long  arm  heterochromatin  presents  such  high  length 
variability among individuals that it can be used to differen-
tiate two male siblings (Rahman et al, 2004). The centro-
meric heterochromatic region is composed of alphoid satel-
lite repeats and also shows significant variability in length 
and sequence among male lineages. Furthermore, this re-
gion also contains several Y-chromosome genetic markers 
commonly used in population studies (Santos et al, 1995). 
 
The euchromatic region of MSY encompasses 23 Mb and 
is made up of three main groups of genes (Skaletsky et al, 
2003). The first group is composed of X-transposed genes, 
represented by two coding units with approximately 99% 
identity to the corresponding X copies. The second group 
consists of 16 coding genes that are generally single-copy 
and  expressed  widely;  however,  some  of  these  are  also 
pseudogenes. The genes in this group are likely relics of 
the ancient autosome pair from which X and Y evolved, 
but  most  of  them  have  X  similarity,  coding  similar  but 
non-identical protein isoforms. The third group is formed 
of genes derived from three converging process; amplifi-
cation of X-degenerated genes, transposition and duplica-
tion or retroposition and duplication of autosomal genes. 
This is a multicopy class that encompasses approximately 
10.2 Mb distributed in Yp and Yq, which consists of large 
regions where gene copies show ~99.9% identity, usually 
maintained  by  gene-conversion.  There  are  eight  palin-
dromic regions, six of which possess genes that are ex-
pressed only in testis. The second and third group of genes 
diverge  in  the  expression  patterns:  the  second  group  is 
involved in cellular housekeeping activities that are impor-
tant for both males and females and the third group is ex-
clusively  composed  of  genes  related  to  male  functions, 
mainly spermatogenesis (Skaletsky et al, 2003). 
 
Recently, Kirsch et al (2005) found eight putative genes 
spread over the pericentromeric Yq11 region. These poten-
tial genes were revealed by sequencing of a 554 kb ge-
nomic  segment containing a 450  kb euchromatic island. 
Four tandem copies of a homeobox-containing DUX gene 
family  were  apparently  functional.  These  finding  open 
new possibilities to search for candidate genes responsible 
for Y chromosome dysfunctions, such as gonadoblastoma 
(GBY, see below). 
 
Y-CHROMOSOME VARIATION AS A POPULATION 
MARKER 
 
The Y-linked loci in the MSY region are haploid, pater-
nally inherited and devoid of recombination with the X-
chromosome. Because of these particular characteristics, 
variation results in the accumulation  of mutations along 
generations, called as paternal or male lineages. Popula-
tion geneticists have extensively studied human male line-
ages  to  trace  migrations  and  reconstruct  human  history 
(reviewed  by  Jobling  and  Tyler-Smith,  2003).  Many  Y-
chromosome  polymorphisms,  also  called  unique  event 
polymorphisms (UEPs), are biallelic markers, and can be 
combined in haplogroups that define Y lineages with spe-
cific  geographic  distributions  around  the  world  (The  Y 
Chromosome Consortium - YCC 2002). Figure 2 shows a 
phylogenetic tree as proposed by the Y-chromosome Con-
sortium (YCC 2002; Jobling and Tyler-Smith, 2003) with 
the  main  haplogroups  defined  by  the  UEPs.  The  hap-
logroup distributions reflect past demographic events and 
human migration routes. The worldwide pattern of distri-
bution  of  the  haplogroups  suggests  a  recent  origin  (be-
tween 60 and 150 thousands years ago) in Africa for all 
present-day human Y-chromosomes (Underhill et al, 2000; 
Wilder et al, 2004). 
 
The worldwide distribution of Y lineages is thought to be a 
consequence  of  random  evolutionary  forces  such  as  ge-
netic drift, population expansion and migration. The influ-
ence of natural selection on these processes is unknown, 
but is usually regarded to be of little significance. How-
ever,  one  cannot  dismiss  natural  selection  so  easily  be-
cause the Y-chromosome carries important genes involved 
in  spermatogenesis,  which  can  be  a  target  for  adaptive 
processes. Two possible selection mechanisms could con-
ceivably have had strong effect in the population genetic 
variation of Y-chromosomes: hitchhiking and background 
selection.  The  hitchhiking  effect  occurs  when  an  allele 
increases in frequency because it is linked to a beneficial 
allele at a neighbouring locus subjected to positive selec-
tion, even if it does not play itself any direct role in fitness 
(Otto, 2000). The background selection process is the op-
posite; in this process an allele is less likely to persist in a 
population and may be eliminated because it is linked to 
deleterious  alleles.  The  consequence  of  these  two  proc-
esses can thus be the spread and eventual fixation, or the 
decrease  and  eventual  extinction  of  a  particular  Y  hap-
logroup or lineage. 
 
Y-CHROMOSOME GENES AND MALE DYSFUNCTION 
 
Skaletsky et al (2003) predicted at least 27 distinct pro-
teins or protein families conferred by the MSY region, 
most of them involved in male specific functions (sper-
matogenesis)  and  in  sex  determination.  Ginalski  et  al 
(2004) used  distinct softwares to detect domains in Y-
chromosome  proteins  and  found  several  DNA-binding 
motifs.  These  findings  suggest  the  existence  of  genes 
whose proteins act as transcriptional repressors, such as 
SRY (sex determining region of chromosome Y), HSFY 
(heat shock transcription factor Y), ZFY (zinc-finger Y) 
and  SMCY  (selected  mouse  cDNA  Y).  Other  identified 
domains are probably involved in protein-protein interac-
tions,  including  complex  assembly  (UTY  –  ubiquitous 
tetracopeptide repeat motif Y), histone binding, histone 
acetylation  and  chromatin  structure  changing  (CDY  – 
chromodomain  Y),  RNA  recognition  (RBMY  –  RNA-
binding motif Y, DAZ – deleted in Azoospermia), etc. The 
emerging picture is of a Y-chromosome protein “pack-
age” involved in regulation of gene expression on differ-
ent  levels  such
  as  transcription,  pre-mRNA  processing 
and translation.  
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Figure 2. Phylogenetic tree of the main Y-chromosome lineages or haplogroups (based on YCC, 2002; Jobling and Tyler-Smith, 
2003). Above the branches are shown loci with derived mutations characterizing each major haplogroup (haplogroup names are be-
low the branches). The subhaplogroup named D2b is also depicted, originating from haplogroup D. 
 
 
 
Y-chromosome and sex reversion 
The first and essential step in normal sexual differentiation 
takes place during the 5th-6th week of gestation. During 
organogenesis the process of cell proliferation, differentia-
tion, migration and death are precisely regulated by com-
plex signaling networks. The Y-chromosome specific SRY 
gene, initially named TDF (testis determining factor), is 
one of the key genes involved in human sex determination: 
It  directs  an  undifferentiated  gonad  into  a  testis,  which 
secretes hormones responsible for normal male develop-
ment (reviewed by Fleming and Vilain, 2004). After this 
event, male development unfolds automatically, unless a 
number  of  genetic  accidents  interrupt  the  male-
determining  pathway,  generating  a  female  baby.  Many 
other genes are required to produce a male (Chaboissier et 
al, 2004), which are being identified through the study of a 
variety  of  sex  reversal  patients  (Vernole  et  al,  2000; 
Saavedra-Castillo et al, 2005). 
Defects or deletions of the SRY gene are assigned as the 
likely cause of 15% of XY females (reviewed by Knower 
et al, 2003). In contrast, males with an XX karyotype usu-
ally present a tiny piece of the Y-chromosome with the 
SRY gene added to the X chromosome. Frequently, these 
reversal events are also associated with other developmen-
tal malformations. The SRY gene, which is located close to 
the Yp-PAR, is responsible for triggering the testis devel-
opment during gonadogenesis. It is a testis-specific tran-
scription factor that plays key role in sexual differentiation 
and development in males. SRY is an intronless gene that 
spans 3.8 kb, with an open reading frame encoding a 204 
amino acids protein with an estimated molecular mass of 
24 kDa. The SRY protein displays a DNA-binding HMG 
(High-Mobility-Group)  box,  a motif  that characterizes  a 
class  of  non-histone  proteins  that  binds  to  a  consensus 
target DNA sequence. The regulation of SRY activity has 
been  suggested  to  proceed  by  acetylation/deacetylation 
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(Thevenet et al, 2004). Houssain and Saunders (2001) re-
ported that the product of the wt1 (Wilms' tumor) gene – 
essential for male sex determination and differentiation in 
mammals – acts as a transcriptional activator of SRY. De-
spite of being discovered 14 years ago, no target gene for 
SRY has been identified so far. The autosomal gene, Sox9, 
a candidate target, encodes a related HMG box-containing 
factor, is up-regulated specifically in XY gonads shortly 
after the onset of SRY transcription and is thought to be 
essential for the differentiation of Sertoli cells (Kent et al, 
1996;  Morais da Silva et al, 1996). Sekido et al (2004) 
found that Sox9 expression is altered in SRY mutants and 
suggested that Sox9 action is downstream of SRY. DAX1, a 
gene placed at the X chromosome, is an orphan nuclear 
receptor originally proposed to act as an “anti-testis” fac-
tor, but Meeks et al (2003) showed that it is required at 
several points of embryonic development. They suggested 
that SRY and DAX1 are both required for testis develop-
ment in humans. 
 
Gonadal dysgenesis, gonadoblastoma and prostate cancer 
Mutations  in  SRY  gene  have  been  reported  in  approxi-
mately 10-15% of 46,XY males with gonadal dysgenesis. 
The majority of the remaining cases may have mutations 
in the SRY regulatory elements or other genes involved in 
the sex differentiation pathway. Recent reports support the 
relationship between SRY alterations, gonadal dysgenesis 
and/or primary infertility (Shahid et al, 2004). 
 
Uehara et al (1999; 2002) found mutations in the SRY gene 
of patients with XY gonadal dysgenesis and gonadal tumor 
formation.  Patients  with  gonadal  dysgenesis  and  Y-
chromosome are at high risk of developing gonadoblastoma, 
a rare benign tumor with potential for malignant transforma-
tion, which affects a subset of patients with intersex disor-
ders. Patients with intersex syndromes presenting gonadal 
dysgenesis  (45,X/46,XY)  and  a  subset  of  patients  with 
Turner syndrome (45,XO) are particularly subjected to de-
veloping gonadoblastoma (Gravholt et al, 2000; Mancilla et 
al, 2003; Mazzanti et al, 2005). Some studies have reported 
an association between the occurrence of gonadoblastoma 
and either macroscopic or molecular evidence of presence 
of a Y-chromosome (Uehara et al, 1999 and 2002). Even 
though  the  gonadoblastoma  diagnosis  is  not  completely 
reliable and the malignant potential
 of the pathogenesis is 
still rather obscure, the presence of Y-chromosome material 
can be definitive for prognostic. Despite the controversial 
studies, in Y-chromosome positive cases the gonadectomy 
is generally recommended (Kondi-Pafiti et al, 2005; Pena-
Alonso et al, 2005). The frequency of intersex patients with 
fragments  of  Y-chromosome  and  presenting  gonadoblas-
toma may vary from 7-10% (Gravholt et al, 2000) to 30% 
(Verp and Simpson, 1987).  
 
It has been hypothesized that the expression of a gene (or 
genes) on the Y-chromosome is directly involved in the 
etiology  of  gonadoblastoma.  Page  (1987)  postulated  the 
existence of a Y-chromosome gene (GBY) with an unde-
fined physiologic function in normal males, which would 
have  the  ability  to  predispose  dysgenetic  gonads  to  de-
velop  malignancy  when  present  in  females.  Women 
46,XY  without  SRY  but  carrying  GBY  locus  developed 
gonadoblastoma  in  their  dysgenic  ovaries.  Using  an  ap-
proach based on STS mapping, Tsuchya et al (1995) iden-
tified a critical region where gonadoblastoma genes could 
be  near  the  Y-chromosome  centromere.  Their  analysis 
indicated two candidate genes – both dispersed Y-linked 
gene  families:  TSPY  (testis-specific  protein  Y-encoded) 
and YRRM (Y-chromosome RNA recognition motif) that 
were present in all gonadoblastoma patients. 
 
YRRM or RBMY gene encodes a nuclear protein containing 
a RNA recognition motif, whose expression is restricted to 
the testis and it is one of the candidate genes related to 
fertility.  It  is  now  considered  an  unlikely  candidate  for 
GBY (Lau, 1999), but Tsuei et al (2004) detected RBMY 
transcripts in testis and liver cancer tissues. Besides, they 
were able to transform rodent fibroblast, suggesting RBMY 
as a candidate oncogene. TSPY gene is present in 20-40 
copies on the human Y-chromosome (or 50 copies accord-
ing to Shubert et al, 2003) and falls dispersed within two 
GBY critical regions: interval 3E-3G and 4B in the short 
arm according to Tsuchiya et al (1995) and intervals 4B 
and 5E in the long arm according to Salo et al (1995). 
TSPY is the  main candidate for GBY and there is some 
evidence supporting its role as an oncogene. Tsuchiya et al 
(1995)  detected  TSPY  expression  of  this  gene  in  tumor 
samples. Recently, Delbridge et al (2004) mapped its ho-
molog in the X chromosome and observed that its cDNA 
was  involved  in  cell  cycle  regulation,  suggesting  that 
TSPY is required for germ cell proliferation. Comparison 
between  TSPY  and  TSPX  sequences  revealed  that  TSPY 
evolved much more rapidly in sequence structure and gene 
copy numbers. TSPY has six exons and occurs in multiple 
copies  but does not form  palindromic repeats like  other 
male specific genes (YRRM and DAZ). Like other testis-
specific  genes,  the  multiple  copies  of  TSPY  have  been 
suggested  to  be  resulted  from  a requirement  for  critical 
doses during spermatogenesis (Graves et al, 1998). 
 
In addition to the evidence of TSPY involvement in gonado-
blastoma, aberrant TSPY expression was also observed in 
prostate cancer tissues and cell lines (Dasari et al, 2001), 
and at elevated levels in tumor cells of prostate cancers at 
various degrees of malignancy (Lau et al, 2003). Vijayaku-
mar et al (2005) transferred a human Y chromosome to a 
human  prostate  cancer  cell lineage  and  found  a  different 
result. They observed that the Y- chromosome suppressed 
tumor  formation  in  athymic  nude  mice.  Paracchini  et  al 
(2003) performed a case-control study using 118 Y markers 
in 930 prostate cancer cases and observed a statistical asso-
ciation between a common Japanese Y-chromosome line-
age, haplogroup O3 (derived from haplogroup O – Figure 2) 
and a fourfold increased risk of severe prostate cancer. It 
would be interesting to verify whether TSPY presents altera-
tion in gene copy number or mRNA transcription and pro-
tein expression in this Japanese male lineage, which could 
be linked to prostate cancer. Taken together, these results 
suggest that the likely association between TSPY or another 
Y chromosome gene and cancer can be much more complex 
than previously understood. 
 
Y-chromosome  genes  and  non-syndromic  hearing 
impairment 
Recently,  Wang  et  al  (2004)  reported  a  Chinese  family 
with  non-syndromic  deafness,  whose  clinical  phenotype  
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was only present in the paternal lineage along seven gen-
erations. Wang et al (2004) suggested a likely candidate in 
Yp11, PCDH11, which codes for a protocadherin protein. 
However, another gene located in Yp, TBL1Y, can be likely 
associated to this dysfunction. This gene, Transducin beta-
like 1Y, has a X chromosome homologue related to a X-
linked late-onset sensorineural deafness (Yan et al, 2005). 
Interestingly, two recent reports pointed out the occurrence 
of  deletions  or  Yp  translocation  associated  to  deafness 
(Graham and Bacino, 2003; Klein et al, 2005). 
 
Y-chromosome genes and male infertility 
In 1976, Tiepolo and Zuffardi observed for the first time 
the involvement of Yq deletions in male infertility when 
they were analyzing cells from idiopathic infertile males. 
Since  then,  many  structural  abnormalities  in  the  Y-
chromosome  have  been  observed, including  microdele-
tions  detectable only  by  molecular methods. Molecular 
studies have shown that microdeletions at Yq11 may rep-
resent  the  etiological  factor  in  as  many  as  10-15%  of 
cases  with  idiopathic  azoospermia  or  severe  oligozoo-
spermia (Reijo et al, 1995; Vogt et al, 1996). The mi-
crodeletion events appear in three critical regions of the 
long arm of the Y-chromosome, initially considered non-
overlapping, called Azoospermia factor (AZFa, AZFb and 
AZFc) (Vogt et al, 1996 – Figure 1). Around 71% of men 
with  Y  chromosomal  microdeletions  and  severe  oligo-
zoospermia  or  idiopathic  azoospermia  were  found  to 
have AZFc deletions compared with 13% with AZFa and 
31% with AZFb deletions (Ferlin et al, 1999; Reynolds 
and  Cooke,  2005).  Challenges  for  current  research  in-
clude  the  elucidation  of  the  genomic  mechanisms  that 
generate such recurrent deletions and also the identifica-
tion of the genes that cause infertility when deleted or 
damaged.  Recombination  between  repetitive  regions  is 
believed to be the cause of the high incidence of de novo 
microdeletions in the Y-chromosome long arm. For in-
stance,  Kuroda-Kawaguchi  et  al  (2001)  demonstrated 
that 47 out of 48 men with AZFc deletions had the same 
proximal and distal breakpoints in 229 kb direct repeats 
flanking AZFc. Furthermore, Repping et al (2002) dem-
onstrated that recombination between repetitive regions 
in  Yq  can  explain  the  majority  of  AZFb  and  AZFb  + 
AZFc deletions. Recently, it was shown that homologous 
recombination  events  are  highly  recurrent  in  the  MSY 
region,  especially  at  the  AZFc  locus  (Skaletsky  et  al, 
2003; Repping et al, 2003; Machev et al, 2004).  
 
The spermatogenic impairment caused by AZFb and AZFc 
deletions can be actually caused by genes mapped at these 
regions as proposed by several studies (Mahadevaiah et al, 
1998; Brown et al, 1998). Since the first deletion mapping 
studies until the most recent and detailed physical map of 
the human Y chromosome (Skaletsky et al, 2003) several 
genes related to spermatogenesis were discovered, which 
are described below. 
 
AZF deletions causing male fertility 
AZFa 
AZFa deletions are rarely found among infertile males but 
usually present more severe consequences than AZFc dele-
tions. Complete deletion of the region is associated with the 
Sertoli-Cell-Only  (SCO)  syndrome,  observed  in  testicular 
biopsies  (Kamp  et  al,  2001).  This  region  spans  approxi-
mately 800 kb (Sun et al, 1999) of Yq and is mapped proxi-
mal to the centromere (Figure 1). AZFa contains two main 
candidate genes: USP9Y (ubiquitin-specific protease 9, also 
known as DFFRY) and DBY/DDX3Y (DEAD/H box poly-
peptide).  Foresta  et  al (2000)  reported well-defined  sper-
matogenic  alterations  carrying  deletions  of  both  genes, 
USP9Y and DBY. They suggested that DBY probably is the 
main AZFa candidate because it is more frequently deleted 
and  its  absence  produces  a  significant  reduction  of  germ 
cells or even their complete absence. The DBY gene has a 
structural  homologue  on  the  short  arm  of  the  X-
chromosome, DBX (Xp11.4). DBY and DBX are transcribed 
in several tissues, however, translation of DBY is detected 
only in the male germ line, predominantly in spermatogonia 
(Ditton et al, 2004). 
 
The USP9Y gene encodes a specific protease that contains 
an  ubiquitin  C-terminal
  hydrolase  domain  (Brown  et  al, 
1998). Studying the USP9Y gene, Sun et al (1999) identified 
the first point mutation causing azoospemia, confirming its 
role in the phenotype and suggesting the requirement for the 
ubiquitin system in spermatogenesis. Despite USP9Y seems 
to play a critical role in human spermatogenesis, the chim-
panzee  Y  chromosome  encodes  a  smaller  USP9Y  ORF, 
without the catalytic domain (Hughes et al, 2005). It is an 
open question whether the chimpanzee USP9Y counterpart 
is inactivated or is still functionally active. 
 
Two paralogous sequences of human endogenous retrovirus 
(HERV) flanking the AZFa locus are diagnosed as the main 
cause of recurrent deletion events and, sometimes duplica-
tions, in this region (Sun et al 2000). HERVs account for 
about 1% of the human genome and are widely distributed 
throughout the chromosomes. The two AZFa HERV copies, 
each one consisting of 10-12 kb in length, are located ~700 
kb apart and present ~94% similarity (Sun et al, 2000). Be-
cause of the long similar sequences between them, they may 
work as substrate for non-homologous recombination, pro-
ducing  chromosomal  rearrangements.  Despite  that  AZFa 
deletions differ among them, most of breakpoints fall within 
the two HERV sequences (Sun et al, 2000).  
 
AZFb or P5/proximal-P1 deletion  
Until recently, AZFb was considered a distinct Yq deletion 
interval, responsible for male infertility in a fraction of idio-
pathic infertile males. However, Repping et al (2002) dem-
onstrated  that  the  previously  considered  non-overlapping 
AZFb deletions actually encompass 1.5 Mb of AZFc, includ-
ing two copies of the main AZFc gene, DAZ. They named 
this  recurrent  deletion  as  P5/proximal-P1,  because  most 
breakpoints  in  this  region  localized  inside  of  P5  and  P1 
proximal palindromes (Repping et al, 2002) (Figure 3). It 
was  also  observed  that  different  length  deletions  have 
breakpoints  localized  in  other  palindromes,  such  as 
P5/distal-P1 and P4/distal-P1, which also delete part of the 
AZFc region. Because the usual markers employed to detect 
alterations  provided  a low resolution  mapping, the actual 
deletion  lengths  were  not  known.  Total  P5/proximal-P1 
deletion encompasses 6.2 Mb and removes 32 genes and 
transcripts.  The  associated  infertile  phenotype  could  be 
caused by the absence of candidate genes in AZFb, or also 
by AZFc candidate genes, or by both.  
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Figure 3. Gene structure of AZFb and AZFc regions with massive presence of repeats and palindromes (adapted from Kuroda-
Kawaguchi et al, 2001; Repping et al, 2002; Skaletsky et al, 2003; Machev et al, 2004). Arrows show copies of the various repeats, 
gene families and palindromes P1 to P5. Cen refers to centromere. (a) The gray bar highlights the main AZFc candidate genes related 
to infertility. The palindromic copies of DAZ and CDY1 genes are shown in detail. Four polymorphic Y chromosome structures (in-
versions a to d) with different gene orders are shown below the gene map. These structures are present in distinct Y haplogroup 
backgrounds (Machev et al, 2004). (b) The gray bars delimit the regions frequently deleted in AZFb/c infertile males: P5/P1.2, 
P5/P1.1, b2/b4 and gr/gr. The outcome of each deletion is dependent on the gene order depicted by some chromosome structure 
polymorphisms as the inversions depicted here. 
 
 
 
The main candidate for causing infertility in AZFb is the 
RBMY gene family, which encodes a nuclear protein con-
taining a RNA recognition motif and whose expression is 
restricted to testis. The presence of an RNA binding motif 
(RBM) and four tandem repeats (SRGY box), similar to 
segments of several splicing factors, indicates a probable 
role of the RBMY protein in RNA metabolism (Ma et al, 
1993). RBMY consists of approximately 30 copies of genes 
and  pseudogenes,  found  on  both  arms  of  the  Y-
chromosome, but probably only the subfamily RBMY1 is 
functional (Chai et al, 1997). RBMY1 is present in AZFb 
and consists of seven slightly different genes. Delbridge et 
al (1999) found an active RBMY homologous copy at X-
chromosome (Xq26), RBMX, which was also shown to be 
present  in  multiple  processed  copies  in  several chromo-
somes (Lingenfelter et al, 2001). According to Lingenfel-
ter et al (2001), RBMY has acquired a testis-specific func-
tion, whereas RBMX is  ubiquitously  expressed and sub-
jected  to  X  inactivation.  Friel  et  al  (2002)  used  reverse 
transcription-polymerase chain reaction (RT-PCR) to ana-
lyze the presence of some infertility AZFb candidate genes 
in  testicular  cells  of  men  with  idiopathic  azoospermia. 
They  found  one  AZFb  deleted  patient  lacking  RBM 
mRNA, corroborating the hypothesis that RBM expression 
is exclusive to AZFb and that the lack of testicular RBMY1 
mRNA results in suppressed spermatogenesis. 
 
Ferlin et al (2003) identified four infertile males with simi-
lar AZFb breakpoints but all of them carrying the candi-
date RBMY. It seems probable that other genes in that re-
gion may be also important in spermatogenesis. The other 
candidate gene encodes for a heat shock protein, HSFY, 
which is deleted in an idiopathic azoospermic male (Vinci 
et al, 2005). 
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AZFc and b2/b4 deletion  
AZFc represents the most frequently deleted region among 
infertile males. The estimated frequency of AZFc deletion 
is approximately  1 in  4000  males, accounting for about 
12% cases of non-obstructive azoospermia and for about 
6% cases of severe oligozoospermia (Kuroda-Kawaguchi 
et  al,  2001).  The  phenotype  observed  in  AZFc  deleted 
males  can  vary  from  azoospermia  to  oligozoospermia, 
including sporadic cases of AZFc deleted males who were 
able  to  conceive  children  naturally  (Gatta  et  al,  2002; 
Kuhnert et al, 2004). Kuroda-Kawaguchi et al (2001) ob-
served that most of deletions share similar breakpoints and 
resulted  from  homologous  recombination  between  two 
direct  repeats  called  b2/b4  (Figure  3).  The  estimated 
length of most of AZFc deletions that arises de novo with 
these characteristics is about 3.5 Mb. 
 
The main candidate gene in AZFc is the DAZ cluster, a set 
of genes transcribed in the adult testis and expressed ex-
clusively in germ cells, apparently encoding an RNA bind-
ing protein (Reijo et al, 1995; Yen et al, 1997). The DAZ 
gene  has  been implicated  in  both  the establishment  and 
maintenance of the primordial germ cell (PGC) population 
as well as in the control of meiotic division (reviewed by 
Reynolds and Cooke, 2005). Using a single male as Y-
reference chromosome, Saxena et al (2000) reported the 
existence of at least four DAZ copies with different num-
bers of intragenic tandem repeats, organized in two blocks, 
each one comprising an inverted pair of DAZ genes, all 
localized in the AZFc region (Figure 3a). The DAZ has a 
homologous  autosomal  copy  on  chromosome  3,  called 
DAZL.  It  presents  high  similarity  to  the  boule  gene  of 
Drosophila,  which  causes  spermatogenic  failure  when 
mutated.  DAZ  genes  in  the  Y-chromosome  are  a  recent 
acquisition in Primates (humans and old world monkeys). 
Mulhall et al (1997) proposed that the DAZ cluster is pref-
erentially involved in quantitative rather than qualitative 
production of sperm. 
 
Infertility predisposition and Y-chromosome variation 
The Y-chromosome has evolved into a highly specialized 
chromosome to perform male functions, mainly spermato-
genesis. The recurrent AZFc deletions associated to infertil-
ity  raise  the  hypothesis  that  some  Y-chromosome  types 
could  be  more  subjected  to  deletions.  Alternatively,  they 
could  carry less  copies  of  spermatogenesis related  genes, 
thus,  such  males  would  present  infertility  predisposition. 
RBMY and DAZ are members of multicopy gene families, 
which  suggest  the  possibility  that  expression  levels  vary 
according to copy gene number. Vogel et al (2000) investi-
gated  the  phenotype  resulting  from  modifications  intro-
duced in RBMY and DAZ in transgenic mice and observed a 
variable penetrance, as we observe in human males with Y-
chromosome deletions. Possibly, environmental effects and 
background genetic profile can change gene expression and 
male phenotype (Mulhal et al, 1997; Foresta et al, 2000). 
Most genes at MSY present motifs  or domains generally 
involved in transcriptional or translational regulation, sup-
porting  the  possible  correlation  between  Y-chromosome 
genes expression and quantitative sperm variation. 
 
Kuroki  et  al  (1999)  found  that  Japanese  males  with  Y-
chromosomes  belonging  to  haplogroup  D  (probably  be-
longing to subhaplogroup D2b – see below) were associ-
ated with low sperm count, suggesting that they are more 
likely  subjected  to  spermatogenic  failure.  Repping  et  al 
(2003)  proposed  an  explanation  of  Kuroki´s  results 
through the observation of a recurrent AZFc deletion of 1.6 
Mb, called gr/gr (Figure 3b). This deletion was observed 
to arise independently in 13 out of 29 lineages of the Y-
chromosome  genealogical  tree.  They  observed  that  one 
specific lineage in Japan, D2b (subtype of D – Figure 2), 
contains  only  gr/gr-deleted  chromosomes.  This  deletion 
does not eliminate all testis-specific genes present in the 
region, but deletes two of four DAZ copies. According to 
Repping et al (2003), men carrying Y-chromosomes with 
gr/gr  deletions should be at  an increased infertility risk, 
since  the  deletion  eliminates  some  transcription  units, 
which would reduce the sperm production. They claimed 
that the D2b haplogroup, which has fixed the gr/gr dele-
tion and occurs in ~30% of Japanese males, is subjected to 
negative selection. 
 
Recent studies conducted in our laboratory found no evi-
dence of significant reduction of fitness related to infertil-
ity when comparing Y haplogroup frequencies from infer-
tile and control males using populations from Israel and 
Japan (Carvalho et al, 2003; 2004). If Japanese males of 
the  haplogroup  D2b  are  subjected to  negative  selection, 
thus predisposed to infertility, we should be able to detect 
significant  haplogroup  differences  between  the  infertile 
and  control  groups.  We  have  recently  improved  our  Y-
chromosome analysis using more UEPs to detect several 
haplogroups, and more STSs from the AZFc region, spe-
cifically to detect  gr/gr deletions. Using these improved 
approaches we obtained the same result, i.e., we could not 
detect any statistical association between Y-chromosome 
haplogroups  and  infertility  predisposition  (unpublished 
data).  Despite  we  had no sperm  count data  for  a  direct 
comparison with their results, it is intriguing that we did 
not observe any increase in D2b males (actually, we ob-
served  a  reduction)  in  the  infertile  group  (25%)  when 
compared  with  the  control  group  (35%).  We  suggested 
that,  probably,  Japanese  gr/gr  chromosomes  may  have 
structural  or  nucleotide  differences  that  compensate  the 
AZFc gene loss, as gain-function alterations. It is also pos-
sible that gr/gr deletions could increase the risk of infertil-
ity in some genetic backgrounds but not in another ones. 
Perhaps,  different  Y-chromosome  lineages  could  have 
different gene numbers of multicopy families involved in 
spermatogenesis,  increasing  or  diminishing  the  effect  of 
gr/gr  deletions.  Interestingly,  recombination  between 
b2/b4 segments from sister chromatids generated duplica-
tion  of DAZ  genes, restoring two copies of DAZ erased 
after  a  gr/gr  deletion  event  (Repping  et  al,  2003).  Of 
course, to properly evaluate the infertility risk we may also 
have  to  consider  variations  in  autosomal  or  X-
chromosomal genes interacting in the spermatogenic com-
plex. These epistatic interactions could be responsible for 
the phenotypic variability in different individuals with a 
gr/gr deletion in their Y-chromosomes. 
 
Despite  the deletion  of the  whole  AZFc  region  leads  to 
sterility, the direct relationship between partial AZFc dele-
tions and infertility is still very controversial. The recent 
findings suggest that AZFc presents a high variability in  
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genomic  structure  among  individuals  (Figure  3a).  Some 
individuals carrying a gr/gr deletion can lose, at least, nine 
transcription units and still be fertile. Machev et al (2004) 
found four different gr/gr deletion types, which remove sev-
eral genes. They also observed several individuals with in-
versions and duplications in the AZFc region (figure 3a), but 
none presented spermatogenic alterations. Those events are 
highly recurrent, occurring in different Y-chromosome line-
ages. Indeed, a particular deletion event (b2/b3) loses 1.8 
Mb from AZFc (Repping et al, 2004). It was suggested to 
happen  in  polymorphic  chromosomes  with  an  inversion 
between gr/rg repeats (see Figure 3a) and subsequent dele-
tion involving repeats b2 and b3. However, there is no evi-
dence of significant reduction in fitness of males from hap-
logroup N (Figure 2), which have the b2/b3 deletion, fixed, 
as we also suggested for the D2b lineage from Japan. 
 
Recent studies (Table 1) have analyzed the association be-
tween gr/gr deletions and infertility. Many of them found a 
positive correlation (Repping et al, 2003; Lynch et al, 2005; 
Ferlin  et  al,  2005;  de  Llanos  et al,  2004;  Giachini  et  al, 
2005), but others not (Hucklenbroich et al, 2004; Machev et 
al, 2004). There are some possible causes to explain those 
disparities, one of them is the lack of agreement in parame-
ters, such as, the sperm count (see Table 1). According to 
WHO  (World  Health  Organization)  recommendations,  an 
individual is considered oligozoospermic if presents sperm 
concentration  <20x10
6  sperm/ml.  However,  Lynch  et  al 
(2005) considered as oligozoospermic those males who pre-
sented ~40x10
6 sperm/ml (table 1). They found association 
between  gr/gr  deleted  males  and  infertility,  but  if  WHO 
recommendations were used, they would have not detected 
a significant association with infertility (see table 1): males 
with >20x10
6 sperm/ml representing 4.6% (Monash Male 
Infertility database) or 5.4% (Men referred for Yq testing), 
similar to azoospermic (3.6% or 5.0%).   
 
Some reports (Machev et al, 2004; Ferlin et al, 2005) have 
showed that the deletion size and the genes excluded in 
each gr/gr deletion can be completely different from each 
other.  This raises another problem,  since gr/gr deletions 
mean  different  Y chromosome  structures and  rearrange-
ments. Furthermore, haplogroup R (Kuroda-Kawaguchi et 
al, 2001) presents four copies  of the DAZ genes, which 
may not be true for all Y chromosomes. Recently, Butler 
and  Schoske  (2005)  studied  the  DYS464  microsatellite, 
which  is  present  in  four  copies  and  located  near  to  the 
DAZ genes. Apparently, most of males have four DYS464 
copies  in  their  Y  chromosomes,  but  they  also  reported 
many males with three to seven copies, which may also 
reflect the number of DAZ genes. Indeed, Lin et al (2005) 
have reported the occurrence of six DAZ copies in differ-
ent Y chromosome lineages (O3, I and R1). Thus, if dif-
ferent Y chromosomes can display two, three, five, six or 
seven DAZ genes, how can we confidently infer gr/gr dele-
tions using only STSs markers? To answer this question it 
will be needed to generate detailed genomic maps through 
sequencing of AZFc regions of different Y chromosome 
lineages with and without gr/gr deletions.  
 
The true role of genes placed at AZFb/c regions as causa-
tive of the infertile phenotype is still a puzzle. Intriguingly, 
a single gene has shown a point mutation causing infertil-
ity (USB9Y, candidate gene of the AZFa region). Genes at 
AZFb/c are correlated to infertility because they are de-
leted  in  some  Y-chromosomes  of  infertile  patients  and 
play a probable role in spermatogenesis, inferred by their 
expression in testis or their X or autosomal homologous 
counterpart. Recently, Ferlin et al (2005) described a fam-
ily case whose father, bearing a gr/gr deleted Y chromo-
some, had five sons. The fertility state of each son, all of 
them are gr/gr deleted, vary from fertile, oligozoospermia 
to azoospermia. Interestingly, the fertility level is corre-
lated to the age of each son. The correlations between the 
sperm production in  gr/gr  males and age have not been 
tested yet, but it seems also an important influence to be 
further evaluated. 
 
This male infertility picture is so complex that the testis 
biopsies  of  males  with  Y-chromosome  deletions  reveal 
diverse  outcomes,  ranging  from  a  complete  absence  of 
germ cells (Sertoli-Cell-Only Syndrome) to the presence 
of cells arrested in different meiotic stages, occasionally 
producing mature sperm (Brandell et al, 1998). Ferlin et al 
(1999) suggested that long deletions are associated with 
the most severe spermatogenic failure, but so far it was not 
possible to establish a definitive correlation between testis 
phenotype  and  infertility  genes.  Many  hypotheses  have 
been postulated to explain such discordant facts. One hy-
pothesis  proposes  the  probable  influence  of  the  genetic 
“background” on fertility among individuals because it is 
estimated  that  >4000  genes  may  be  involved  in  human 
spermatogenesis (Gianotten et al, 2004). Meschede et al 
(2000)  demonstrated  familial  clustering  associated  with 
male infertility, corroborating this view. Moreover, envi-
ronmental factors are also likely to influence the pheno-
type and the advanced paternal age has also been pointed 
out as a contributing factor. 
 
Nevertheless, much evidence suggests another interesting 
hypothesis. It  may  be possible that infertility in AZFb/c 
deleted  males  may  not  be  caused  by  the  absence  of  Y 
genes itself but  due to the impairment of the spermato-
genic process either because of the lack of 6.1 Mb AZFb 
deletion or 3.5 Mb AZFc deletion. Yogev et al (2004) ob-
served a strong impairment in the normal alignment of X 
and  Y  pseudo-autosomal  regions  (PARs)  in  AZFb-c  de-
leted individuals (~29%) and a moderated decrease (70-
94%) in AZFc deleted males. It has been suggested that the 
spermatogenic failure could  be either caused by  the ab-
sence of genes necessary to bivalent formation complex in 
meiosis  or  by  recombination  disturbance  caused  by  the 
absence of a long DNA stretch. If the first possibility were 
true, we would expect lower bivalent formation involving 
other chromosome pairs, unless Y infertility  genes were 
specific  for  bivalent  Y-chromosome  complex  formation. 
Solari (1999) observed the heterogeneous stages of mei-
otic cell degeneration in the histopathology of cells carry-
ing chromosomal abnormalities, which could be compared 
to the spermatogenesis infertile male picture (arrested in 
different meiotic stages). Nevertheless, in most mammals, 
the DAZL alone is sufficient for complete gametogenesis 
(Skaletsky et al, 2003). Vogel et al (2002) used transgenic 
mice carrying either human DAZL or human DAZ (Y) on a 
mouse DAZL-knockout and observed that both transgenics 
enabled  partial  rescue  of  the  spermatogenesis  failure. 
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Table 1.  Comparative data of recent studies about gr/gr deletions and male infertility 
 
Reports  N  Spermatogenic failure  gr/gr 
N (%)  Y haplogroups  Association 
gr/gr + infertility 
471  Non-obstructive azoospermia 
or oligozoospermia (<5x10
6 
sperm/ml) 
15 (3.2)  DE* (xD2b) 
F*(xJK) 
J 
K*(xP) 
P*(xR1a) 
246  <10x10
6 sperm/ml or <20x10
6 
total 
 9 (3.7)  DE* (xD2b) 
P*(xR1a) 
R1A 
215  Unknown fertility   4 (1.9)  D2b, J,  
K*(xP) 
Repping et al 2003 
148  Controls: >40x10
6 total   0  - 
Yes 
Lynch et al 2005  197  Azoospermia  7  (3.6) 
119  0.1–0.5x10
6 sperm/ml  4 (3.4) 
188  0.6–5.0x10
6 sperm/ml  8 (4.3) 
122  5.0–19x10
6 sperm/ml  4 (3.3) 
56  20–40x10
6 sperm/ml  1 (1.8) 
Monash Male Infer-
tility (MMI) data-
base 
 
106  >40x10
6 sperm/ml  3 (2.8) 
119  Azoospermia  6 (5.0) 
131  0.1–0.5x10
6 sperm/ml  3 (2.3) 
198  0.6–5.0x10
6 sperm/ml  12 (6.0) 
114  >5.0–19x10
6 sperm/ml  5 (4.4) 
Men referred for Y 
chromosome (Yq) 
testing 
37  ≥20x10
6sperm/ml  2 (5.4) 
  234  Controls  1 (0.4) 
All gr/gr: 
E, F*(xJK), J, 
K*(xP),  
P*(xR1a) 
Yes 
73  Azoospermia  3 (4.1) 
193  <5.0x10
6 sperm/ml  10 (5.2) 
71  5.0–20x10
6 sperm/ml  3 (4.2) 
Ferlin et al 2005 
263  Controls: >20x10
6 sperm/ml  1 (0.4) 
- 
Yes 
66  Azoospermia  12 (4.2) 
217  <5x10
6 sperm/ml  11 (5.1) 
De Llanos et al 2004 
232  Controls   0 
- 
Yes 
89  Idiopathic infertile males  4 (4.5) 
61  Males with mild abnormal 
andrological findings 
3 (4.9) 
Giachini et al 2005 
189  Controls  1 (0.5) 
- 
Yes 
61  Azoospermia  2 (3.3) 
133  <1.0 x10
6 sperm/ml  6 (4.5) 
154  1.0–20x10
6 sperm/ml  6 (3.9) 
Hucklenbroich et al 
2005 
170  Controls  3 (1.8) 
All gr/gr: 
F*(xIJK),  
R1 
No 
263  Azoospermia or 
Oligozoospermia <5x106 
sperm/ml 
15 (5.7)  DE, J, P,  
Y*(xDEJP) 
46  >5x10
6 sperm/ml  3 (6.5)  DE, J, P 
210  Unknown fertility  10 (4.8)  J, P, 
Y*(xDEJP) 
Machev et al 2004 
189   Controls  6 (3.2)  DE,  
Y*(xDEJP) 
No 
 
 
However, the autosomal gene resulted in a larger amount 
of early  germ cells,  but this proposal still  needs further 
investigation. 
  
CONCLUSION 
 
The human Y chromosome has just been completely se-
quenced  (Skaletsky  et  al,  2003)  but  a  lot  of  work  still 
needs to be done to reveal its role in maleness. The pecu-
liar nature of its genes, mostly appearing in multiple cop-
ies,  generates  difficulties  for  understanding  its  function 
and the correlation between genotype and phenotype. Be-
sides, the DNA sequence of a single Y-chromosome re-
veals only a snapshot of a dynamic chromosome, which 
presents several distinct gene structures among individuals 
(Figure  3a).  It  poses  a  dramatic  challenge  to  molecular  
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biologists  and  medical  geneticists  investigating  Y-
chromosome-mediated dysfunctions, and also reveals the 
complexity of the functional pathways related to inherited 
disorders affecting humans. 
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